Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
about
Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants.Nucleus accumbens functional connectivity at age 20 is associated with trajectory of adolescent cannabis use and predicts psychosocial functioning in young adulthood.Neural responses to negative outcomes predict success in community-based substance use treatment.Replication in Imaging Genetics: The Case of Threat-Related Amygdala Reactivity.
P2860
Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
@en
type
label
Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
@en
prefLabel
Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
@en
P2093
P2860
P356
P1476
Clinical neuroprediction: Amygdala reactivity predicts depressive symptoms 2 years later.
@en
P2093
Christopher S Monk
Daniel S Shaw
Erika E Forbes
Luke W Hyde
Whitney I Mattson
P2860
P304
P356
10.1093/SCAN/NSW018
P577
2016-02-10T00:00:00Z